miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2

Liu, HT; Luo, CP; Jiang, MJ; Deng, ZJ; Teng, YX; Su, JY; Pan, LX; Ma, L; Guo, PP; Zhong, JH

Zhong, JH (通讯作者)，Guangxi Med Univ, Canc Hosp, Hepatobiliary Surg Dept, He Di Rd 71, Nanning 530021, Peoples R China.;Guo, PP (通讯作者)，Guangxi Med Univ, Canc Hosp, Dept Ultrasound, He Di Rd 71, Nanning 530021, Peoples R China.;Zhong, JH (通讯作者)，Guangxi Med Univ, Minist Educ, Key Lab Early Prevent & Treatment Reg High Frequen, Nanning, Peoples R China.;Zhong, JH (通讯作者)，Guangxi Key Lab Early Prevent & Treatment Reg High, Nanning, Peoples R China.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023; 25 (10): 2960

Abstract

Objective Downregulation of miR-17-5p has been reported in several cancers, but whether and how miR-17-5p is downregulated in hepatocellular carcinoma......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索